Roche reports interim results for phase-III Skycraper-01 study in PD-L1-high metastatic non-small…
The study evaluating Tiragolumab plus Tecentriq did not meet its co-primary endpoint of progression-free survival
Recover your password.
A password will be e-mailed to you.